AA
AMGN icon

AlphaCentric Advisors’s Amgen AMGN Stock Holding History

AlphaCentric Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$819K Buy
2,329
+127
+6% +$45.3K 0.82% 26
2025
Q4 		$721K Buy
+2,202
New +$698K 0.72% 38
2023
Q4 		– Sell
-890
Closed -$239K – 225
2023
Q3 		$239K Sell
890
-28
-3% -$6.99K 0.14% 129
2023
Q2 		$204K Sell
918
-64
-7% -$14.8K 0.11% 147
2023
Q1 		$237K Sell
982
-10
-1% -$2.46K 0.16% 134
2022
Q4 		$261K Buy
+992
New +$266K 0.26% 118

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AlphaCentric Advisors's AMGN Position: Q1 2026 in Review

AlphaCentric Advisors increased its Amgen (AMGN) stake by 5.8% in Q1 2026, buying an estimated $45.3K and bringing the position to 2,329 shares worth $819K. The position accounts for 0.82% of the portfolio, ranked #26.

AlphaCentric Advisors first reported a position in AMGN in Q4 2022 and has held it in 6 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AlphaCentric Advisors held 2,329 shares of Amgen worth $819K as of Q1 2026.
  • AlphaCentric Advisors bought 127 Amgen shares in Q1 2026, an estimated $45.3K.
  • Amgen made up 0.82% of AlphaCentric Advisors's portfolio in Q1 2026, its #26 holding.
  • AlphaCentric Advisors first reported a position in Amgen in Q4 2022 and has held it in 6 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.